Ignite Creation Date:
2024-05-06 @ 7:42 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02589496
Status:
COMPLETED
Last Update Posted:
2023-05-09
First Post:
2015-10-27
Brief Title:
Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine Integration of Molecular Subtypes Through Integrative Genomic Analysis
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gastroesophageal Junction Adenocarcinoma |
| Gastric Adenocarcinoma |
Keywords: